GSK plc Increase Decrease In Contingent Liabilities Recognised In Business Combination
GSK plc (GSK) reported Increase Decrease In Contingent Liabilities Recognised In Business Combination of -GBP 581.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInContingentLiabilitiesRecognisedInBusinessCombination · last filed 2026-03-06
| Period end | Increase Decrease In Contingent Liabilities Recognised In Business Combination 12 month |
|---|---|
| 2025-12-31 | -581.00M GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | -1.75B GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | -791.00M GBP 20-F · filed 2026-03-06 |
| 2022-12-31 | -1.61B GBP 20-F · filed 2025-03-03 |
| 2021-12-31 | -1.06B GBP 20-F · filed 2024-03-05 |
| 2020-12-31 | -1.29B GBP 20-F · filed 2023-03-10 |
| 2019-12-31 | -92.00M GBP 20-F · filed 2022-03-08 |
| 2018-12-31 | -1.25B GBP 20-F · filed 2021-03-12 |
| 2017-12-31 | -1.01B GBP 20-F · filed 2020-03-06 |
| 2016-12-31 | -2.21B GBP 20-F · filed 2019-03-15 |
| 2015-12-31 | -1.97B GBP 20-F/A · filed 2018-03-20 |